BioSpace News Archive

Drug Development

DiscGenics Announces Completion of Enrollment in U.S. Phase 1/2 Clinical Trial of Discogenic Cell Therapy for Degenerative Disc Disease

DiscGenics, Inc. , a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it has completed enrollment in its Phase 1/2 first-in-human U.S. clinical study of IDCT

March 4, 2020
·
6 min read
Deals

Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing of a definitive agreement, subject to conditions precedent, to acquire ImmunXperts.

March 4, 2020
·
3 min read
Pharm Country

Stem Cells Market Enormous Growth 2020 | Exclusive Profitable Comprehensive Report Forecast To 2029

The report carefully examines the Stem Cells Market, with a focus on most of the major players and their business strategies, geographical scope, market segments, product landscape and price, and cost structure.

March 4, 2020
·
6 min read
BioCapital

New Telehealth Capability Helps Healthcare Providers Connect with Patients and Other Clinicians in Novel Ways

DrFirst™ and Agora partner to add telehealth to Backline HIPAA-compliant care collaboration platform

March 4, 2020
·
3 min read
Genetown

Biofourmis’ AI-Powered Remote Monitoring Platform to Provide New Insights to Fight COVID-19 in Disease Monitoring Program in Hong Kong

First-of-its-kind program administered by The University of Hong Kong has international implications and applications as COVID-19 continues to spread

March 4, 2020
·
5 min read
Mallinckrodt Announces Publication of New Data on Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Dermatomyositis/Polymyositis Published in Open Access Rheumatology: Research and Reviews

Retrospective chart review assessing Acthar Gel treatment utilization and patterns in 92 patients suggests improvement in symptoms across three disease states in a real-world setting

March 4, 2020
·
17 min read
Business

Encompass Health to discuss longer term business outlook at its 2020 investor day

Encompass Health Corp. (NYSE: EHC) will host its 2020 investor day today in New York City. Encompass Health President & Chief Executive Officer Mark Tarr will outline the integrated healthcare service provider’s longer term business outlook for the Company.

March 4, 2020
·
6 min read
Biotech Bay

Amunix Raises $73 Million in Series A Financing Led by Omega Funds

Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers, today announced the successful completion of an oversubscribed $73 million Series A financing.

March 4, 2020
·
5 min read
Genetown

AMAG Pharmaceuticals Announces Changes to Medical Development Organization

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced changes to its medical development organization.

March 4, 2020
·
6 min read
Business

Recro Reports Financial Results for the Year Ended 2019

Recro Pharma, Inc. (Nasdaq:REPH), a high-performing, revenue generating contract development and manufacturing organization (CDMO), today reported financial results for the year ended December 31, 2019.

March 4, 2020
·
14 min read